UniProt ID | IF4A3_HUMAN | |
---|---|---|
UniProt AC | P38919 | |
Protein Name | Eukaryotic initiation factor 4A-III | |
Gene Name | EIF4A3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 411 | |
Subcellular Localization | Nucleus . Nucleus speckle . Cytoplasm . Nucleocytoplasmic shuttling protein. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. Detected in dendritic layer as well as the nuclear and cytoplasmic (somatic) compartments | |
Protein Description | ATP-dependent RNA helicase. [PubMed: 16170325 Involved in pre-mRNA splicing as component of the spliceosome] | |
Protein Sequence | MATTATMATSGSARKRLLKEEDMTKVEFETSEEVDVTPTFDTMGLREDLLRGIYAYGFEKPSAIQQRAIKQIIKGRDVIAQSQSGTGKTATFSISVLQCLDIQVRETQALILAPTRELAVQIQKGLLALGDYMNVQCHACIGGTNVGEDIRKLDYGQHVVAGTPGRVFDMIRRRSLRTRAIKMLVLDEADEMLNKGFKEQIYDVYRYLPPATQVVLISATLPHEILEMTNKFMTDPIRILVKRDELTLEGIKQFFVAVEREEWKFDTLCDLYDTLTITQAVIFCNTKRKVDWLTEKMREANFTVSSMHGDMPQKERESIMKEFRSGASRVLISTDVWARGLDVPQVSLIINYDLPNNRELYIHRIGRSGRYGRKGVAINFVKNDDIRILRDIEQYYSTQIDEMPMNVADLI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MATTATMA -------CCCCHHHC | 7.25 | 21406692 | |
2 | Acetylation | ------MATTATMAT ------CCCCHHHCC | 17.41 | 20068231 | |
3 | Phosphorylation | -----MATTATMATS -----CCCCHHHCCC | 18.70 | 21955146 | |
4 | Phosphorylation | ----MATTATMATSG ----CCCCHHHCCCH | 15.59 | 25159151 | |
6 | Phosphorylation | --MATTATMATSGSA --CCCCHHHCCCHHH | 12.78 | 25159151 | |
9 | Phosphorylation | ATTATMATSGSARKR CCCHHHCCCHHHHHH | 23.85 | 29255136 | |
10 | Phosphorylation | TTATMATSGSARKRL CCHHHCCCHHHHHHH | 22.63 | 29255136 | |
12 | Phosphorylation | ATMATSGSARKRLLK HHHCCCHHHHHHHHC | 25.35 | 29255136 | |
14 | Methylation | MATSGSARKRLLKEE HCCCHHHHHHHHCHH | 26.73 | - | |
19 | Acetylation | SARKRLLKEEDMTKV HHHHHHHCHHHCCCE | 64.74 | 25953088 | |
19 | 2-Hydroxyisobutyrylation | SARKRLLKEEDMTKV HHHHHHHCHHHCCCE | 64.74 | - | |
19 | Ubiquitination | SARKRLLKEEDMTKV HHHHHHHCHHHCCCE | 64.74 | - | |
19 | Sumoylation | SARKRLLKEEDMTKV HHHHHHHCHHHCCCE | 64.74 | 28112733 | |
19 | Sumoylation | SARKRLLKEEDMTKV HHHHHHHCHHHCCCE | 64.74 | - | |
31 | Phosphorylation | TKVEFETSEEVDVTP CCEEEECCCCEECCC | 25.27 | - | |
54 | Phosphorylation | EDLLRGIYAYGFEKP HHHHHHHHHHCCCCC | 9.15 | 28152594 | |
56 | Phosphorylation | LLRGIYAYGFEKPSA HHHHHHHHCCCCCHH | 12.84 | 28152594 | |
60 | Sumoylation | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | - | |
60 | 2-Hydroxyisobutyrylation | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | - | |
60 | Acetylation | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | 23954790 | |
60 | Malonylation | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | 26320211 | |
60 | Ubiquitination | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | 21890473 | |
60 | Sumoylation | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | - | |
60 | Methylation | IYAYGFEKPSAIQQR HHHHCCCCCHHHHHH | 41.85 | - | |
62 | Phosphorylation | AYGFEKPSAIQQRAI HHCCCCCHHHHHHHH | 49.42 | 28152594 | |
70 | Acetylation | AIQQRAIKQIIKGRD HHHHHHHHHHHCCCC | 34.16 | 25953088 | |
70 | 2-Hydroxyisobutyrylation | AIQQRAIKQIIKGRD HHHHHHHHHHHCCCC | 34.16 | - | |
70 | Methylation | AIQQRAIKQIIKGRD HHHHHHHHHHHCCCC | 34.16 | 23748837 | |
70 | Ubiquitination | AIQQRAIKQIIKGRD HHHHHHHHHHHCCCC | 34.16 | - | |
82 | Phosphorylation | GRDVIAQSQSGTGKT CCCEEEECCCCCCCE | 19.79 | 27282143 | |
84 | Phosphorylation | DVIAQSQSGTGKTAT CEEEECCCCCCCEEE | 43.50 | 25159151 | |
86 | Phosphorylation | IAQSQSGTGKTATFS EEECCCCCCCEEEEE | 40.53 | 27732954 | |
124 | Acetylation | ELAVQIQKGLLALGD HHHHHHHHHHHHHCC | 53.83 | - | |
132 | Phosphorylation | GLLALGDYMNVQCHA HHHHHCCCCCCEECE | 6.70 | - | |
152 | 2-Hydroxyisobutyrylation | NVGEDIRKLDYGQHV CCCHHHHHCCCCCEE | 46.15 | - | |
152 | Acetylation | NVGEDIRKLDYGQHV CCCHHHHHCCCCCEE | 46.15 | 26051181 | |
152 | Malonylation | NVGEDIRKLDYGQHV CCCHHHHHCCCCCEE | 46.15 | 26320211 | |
152 | Ubiquitination | NVGEDIRKLDYGQHV CCCHHHHHCCCCCEE | 46.15 | - | |
155 | Phosphorylation | EDIRKLDYGQHVVAG HHHHHCCCCCEEECC | 29.17 | 27273156 | |
163 | Phosphorylation | GQHVVAGTPGRVFDM CCEEECCCCCHHHHH | 16.91 | 22167270 | |
182 | 2-Hydroxyisobutyrylation | SLRTRAIKMLVLDEA HHHHHHHHHHHCHHH | 25.79 | - | |
182 | Ubiquitination | SLRTRAIKMLVLDEA HHHHHHHHHHHCHHH | 25.79 | 21906983 | |
182 | Acetylation | SLRTRAIKMLVLDEA HHHHHHHHHHHCHHH | 25.79 | 25953088 | |
195 | Ubiquitination | EADEMLNKGFKEQIY HHHHHHHHHHHHHHH | 62.86 | 21906983 | |
195 | 2-Hydroxyisobutyrylation | EADEMLNKGFKEQIY HHHHHHHHHHHHHHH | 62.86 | - | |
195 | Acetylation | EADEMLNKGFKEQIY HHHHHHHHHHHHHHH | 62.86 | 25953088 | |
198 | Ubiquitination | EMLNKGFKEQIYDVY HHHHHHHHHHHHHHH | 58.33 | 21890473 | |
198 | Acetylation | EMLNKGFKEQIYDVY HHHHHHHHHHHHHHH | 58.33 | 25825284 | |
198 | Malonylation | EMLNKGFKEQIYDVY HHHHHHHHHHHHHHH | 58.33 | 26320211 | |
202 | Phosphorylation | KGFKEQIYDVYRYLP HHHHHHHHHHHHHCC | 10.07 | 27273156 | |
205 | Phosphorylation | KEQIYDVYRYLPPAT HHHHHHHHHHCCCCC | 7.22 | 28152594 | |
218 | Phosphorylation | ATQVVLISATLPHEI CCEEEEEECCCCHHH | 15.84 | - | |
242 | Acetylation | DPIRILVKRDELTLE CCEEEEECCCCCCHH | 51.16 | 26051181 | |
247 | Phosphorylation | LVKRDELTLEGIKQF EECCCCCCHHHHHHH | 22.25 | - | |
264 | Ubiquitination | AVEREEWKFDTLCDL EEECCCCCHHHHHHH | 36.32 | - | |
276 | O-linked_Glycosylation | CDLYDTLTITQAVIF HHHHHHEEEEEEHHH | 24.87 | 32119511 | |
278 | O-linked_Glycosylation | LYDTLTITQAVIFCN HHHHEEEEEEHHHCC | 12.77 | 32119511 | |
287 | Ubiquitination | AVIFCNTKRKVDWLT EHHHCCCCCCHHHHH | 35.91 | - | |
289 | Malonylation | IFCNTKRKVDWLTEK HHCCCCCCHHHHHHH | 46.21 | 26320211 | |
289 | Acetylation | IFCNTKRKVDWLTEK HHCCCCCCHHHHHHH | 46.21 | 27452117 | |
289 | 2-Hydroxyisobutyrylation | IFCNTKRKVDWLTEK HHCCCCCCHHHHHHH | 46.21 | - | |
289 | Ubiquitination | IFCNTKRKVDWLTEK HHCCCCCCHHHHHHH | 46.21 | - | |
296 | Acetylation | KVDWLTEKMREANFT CHHHHHHHHHHCCCE | 37.71 | 19608861 | |
296 | 2-Hydroxyisobutyrylation | KVDWLTEKMREANFT CHHHHHHHHHHCCCE | 37.71 | - | |
296 | Ubiquitination | KVDWLTEKMREANFT CHHHHHHHHHHCCCE | 37.71 | 19608861 | |
303 | Phosphorylation | KMREANFTVSSMHGD HHHHCCCEEEECCCC | 21.20 | 28509920 | |
306 | Phosphorylation | EANFTVSSMHGDMPQ HCCCEEEECCCCCCH | 15.51 | 28509920 | |
314 | 2-Hydroxyisobutyrylation | MHGDMPQKERESIMK CCCCCCHHHHHHHHH | 53.52 | - | |
314 | Sumoylation | MHGDMPQKERESIMK CCCCCCHHHHHHHHH | 53.52 | 28112733 | |
314 | Acetylation | MHGDMPQKERESIMK CCCCCCHHHHHHHHH | 53.52 | 25953088 | |
314 | Ubiquitination | MHGDMPQKERESIMK CCCCCCHHHHHHHHH | 53.52 | 21906983 | |
321 | Ubiquitination | KERESIMKEFRSGAS HHHHHHHHHHHHCCC | 52.62 | 21906983 | |
321 | Acetylation | KERESIMKEFRSGAS HHHHHHHHHHHHCCC | 52.62 | 19608861 | |
321 | 2-Hydroxyisobutyrylation | KERESIMKEFRSGAS HHHHHHHHHHHHCCC | 52.62 | - | |
333 | Phosphorylation | GASRVLISTDVWARG CCCEEEEECCHHHCC | 17.88 | 29978859 | |
334 | Phosphorylation | ASRVLISTDVWARGL CCEEEEECCHHHCCC | 27.81 | 29978859 | |
347 | Phosphorylation | GLDVPQVSLIINYDL CCCCCEEEEEEEEEC | 14.49 | 29978859 | |
352 | Phosphorylation | QVSLIINYDLPNNRE EEEEEEEEECCCCCE | 14.40 | 29978859 | |
374 | Ubiquitination | RSGRYGRKGVAINFV CCCCCCCCCEEEEEE | 54.06 | 21906983 | |
374 | Methylation | RSGRYGRKGVAINFV CCCCCCCCCEEEEEE | 54.06 | 23748837 | |
374 | Acetylation | RSGRYGRKGVAINFV CCCCCCCCCEEEEEE | 54.06 | 26051181 | |
382 | Ubiquitination | GVAINFVKNDDIRIL CEEEEEECCCCCCHH | 50.99 | 21890473 | |
382 | Acetylation | GVAINFVKNDDIRIL CEEEEEECCCCCCHH | 50.99 | 23749302 | |
382 | 2-Hydroxyisobutyrylation | GVAINFVKNDDIRIL CEEEEEECCCCCCHH | 50.99 | - | |
382 | Succinylation | GVAINFVKNDDIRIL CEEEEEECCCCCCHH | 50.99 | 23954790 | |
382 | Sumoylation | GVAINFVKNDDIRIL CEEEEEECCCCCCHH | 50.99 | 28112733 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IF4A3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IF4A3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
268305 | Richieri-Costa-Pereira syndrome (RCPS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-10 AND SER-12, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60; LYS-296 AND LYS-321, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-10 AND SER-12, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-163, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-163, AND MASSSPECTROMETRY. |